Intravenous amiodarone for cardioversion of recent-onset atrial fibrillation

Clinical Cardiology

Volumn 26, Issue 7, 2003, Pages 329-335

  Cybulski, Jacek ^a   Kułakowski, Piotr ^a   Budaj, Andrzej ^a   Danielewicz, Henryk ^b   Maciejewicz, Janusz ^c   Kawka Urbanek, Teresa ^d   Ceremuzyński, Leszek ^a  

^a GROCHOWSKI HOSPITAL   (Poland)

^b Biega skiego Hospital   (Poland)

^c Dietla Hospital   (Poland)

^d Provincial Hospital   (Poland)

Author keywords

Amiodarone; Pharmacologic cardioversion; Recent onset atrial fibrillation

Indexed keywords

AMIODARONE; GLUCOSE; INSULIN; MAGNESIUM SULFATE; POTASSIUM CHLORIDE;

ADULT; AGED; ARTICLE; ASYSTOLE; BRADYCARDIA; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DILUTION; DISEASE DURATION; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART RHYTHM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT MONITORING; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SINUS RHYTHM;

EID: 0037662805     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4950260707     Document Type: Article

References (19)

1. Bialy D, Lehman MH, Schumacher DN: Hospitalization for arrhythmia in the United States. Importance of atrial fibrillation. J Am Coll Cardiol 1992;19(suppl. A):41A
2. Kannel W, Abbott RD, Savage DD, McNamara P: Epidemiologic features of atrial fibrillation: The Framingham Study. N Engl J Med 1982;306: 1018-1022
3. Pritchett E: Management of atrial fibrillation. N Engl J Med 1992;326: 1264-1271
4. Ganz LI, Antman EM: Antiarrhythmic drug therapy in the management of atrial fibrillation. J Cardiovasc Electrophysiol 1997;8:1175-1189
5. Masoudi FA, Goldschlager N: The medical management of atrial fibrillation. Cardiol Clin 1997;15:689-719
6. Donovan KD, Power BM, Hockings BEF, Dobb GJ, Lee K-Y: Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation. Am J Cardiol 1995;75:693-697
7. Kochiadakis GE, Igoumenidis NE, Simantirakis EN, Marketou ME, Parthenakis FI, Mezilis NE, Vardas PE: Intravenous proAFenone versus intravenous amiodarone in management of atrial fibrillation of recent onset: A placebo-controlled study. PACE 1998;21:2475-2479
8. Cotter G, Blatt A, Kaluski E, Metzkor-Cotter M, Koren M, Litinski I, Simantov R, Moshkovitz Y, Zaidenstein R, Peleg E, Vered Z, Golik A: Conversion of recent-onset paroxysmal atrial fibrillation to normal sinus rhythm: The effect of no treatment and high-dose amiodarone. A randomised, placebo-controlled study. Eur Heart J 1999;20:1833-1842
9. Martinez-Marcos FJ, Garcia-Garmendia JL, Ortega-Carpio A, Fernandez-Gomez JM, Santos JM, Camacho C: Comparison of intravenous flecainide, proAFenone and amiodarone for conversion of acute atrial fibrillation to sinus rhythm. Am J Cardiol 2000;86:950-953
10. Dell'Orfano JT, Patel H, Wolbrette D, Luck JC, Nacarelli CV: Acute treatment of atrial fibrillation: Spontaneous conversion rates and cost of care. Am J Cardiol 1999;83:788-790
11. Negrini M, Gibelli G, De Ponti C: A comparison of proAFenone and amiodarone in reversion of recent-onset atrial fibrillation to sinus rhythm. Curr Therapeut Res 1994;55:1345-1354
12. Hou Z-Y, Chang C-Y, Chen M-S, Tu MS, Lin SL, Chiang HT, Woosley RL: Acute treatment of recent-onset atrial fibrillation and flutter with tailored dosing regimen of intravenous amiodarone. A randomised, digoxin-controlled study. Eur Heart J 1995;16:521-528
13. Galve E, Rius T, Ballester R, Artaza MA, Arnau JM, Garcia-Dorado D, Soler-Soler J: Intravenous amiodarone in treatment of recent-onset atrial fibrillation: Results of a randomised, controlled study. J Am Coll Cardiol 1996;27:1079-1082
14. Boriani G, Biffi M, Capucci A, Botto G, Ongari M, Trisolino G, Rubino I, Sanguinetti M, Branzi A, Mangani B: Conversion of recent-onset atrial fibrillation to sinus rhythm: Effects of different drug protocols. PACE 1998;21:2470-2474
15. Peuhkurinen K, Niemela M, Ylitalo A, Linnaluoto M, Lilja M, Juvonen J: Effectiveness of amiodarone as single oral dose for recent onset atrial fibrillation. Am J Cardiol 2000;85:462-465
16. Joseph AP, Ward MR: A prospective, randomized, controlled trial comparing the efficacy and safety of sotalol, amiodarone and digoxin for the reversion of new-onset atrial fibrillation. Ann Emerg Med 2001;36:1-9
17. Hohnloser SH, Meinertz T, Demmbacher T, Steiert K, Jahnchen E, Zehender M, Fraedrich G, Just H: Electrocardiographic and antiarrhythmic effects of intravenous amiodarone. Results of prospective placebo-controlled study. Am Heart J 1991;121:89-95
18. Kulakowski P, Karczmarewicz S, Karpinski G, Soszynska M, Ceremuzynski L: Effects of intravenous amiodarone on ventricular refractoriness, intraventricular conduction and ventricular tachycardia induction. Europace 2000;2:207-215
19. Boriani G, Biffi M, Capucci A, Botto GL, Broffoni T, Rubino I, Della Casa S, Sanguinetti M, Magnani B: Oral proAFenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. Ann Intern Med 1997;126:621-625